What caused lymphopenia in SARS and how reliable is the lymphokine status in glucocorticoid-treated patients?

Medical Hypotheses

Volumn 71, Issue 2, 2008, Pages 298-301

  Panesar, N S ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ANTIVIRUS AGENT; GLUCOCORTICOID; HYDROCORTISONE; LYMPHOKINE;

ARTICLE; CORONAVIRUS; CYTOKINE PRODUCTION; DOWN REGULATION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LYMPHOCYTE; LYMPHOCYTOPENIA; MACROPHAGE; MORBIDITY; MORTALITY; NEUTROPHIL; NEUTROPHILIA; PRIORITY JOURNAL; PROGNOSIS; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; STEROID THERAPY; STRESS; VIRUS HEMORRHAGIC FEVER;

CYTOKINES; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; HYPOTHALAMUS; IMMUNE SYSTEM; LYMPHOCYTES; LYMPHOKINES; LYMPHOPENIA; MODELS, BIOLOGICAL; MODELS, THEORETICAL; PITUITARY-ADRENAL SYSTEM; PROGNOSIS; SEVERE ACUTE RESPIRATORY SYNDROME;

RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS; SARS CORONAVIRUS;

EID: 45649084021     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2008.03.019     Document Type: Article

References (36)

1. Anand K., Ziebuhr J., Wadhwani P., Mesters J.R., and Hilgenfeld R. Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs. Science 300 (2003) 1763-1767
2. Ho J.C., Ooi G.C., Mok T.Y., et al. High-dose pulse versus nonpulse corticosteroid regimens in severe acute respiratory syndrome. Am J Respir Crit Care Med 168 (2003) 1449-1456
3. Sung J.J.Y., Wu A., Joynt G.M., et al. Severe acute respiratory syndrome: report of treatment and outcome after a major outbreak. Thorax 59 (2004) 414-420
4. Lee N., Hui D., Wu A., et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. New Engl J Med 348 (2003) 1986-1994
5. Booth C.M., Matukas L.M., Tomlinson G.A., et al. Clinical features and short-term outcomes of 144 patients with SARS in the greater toronto area. Jama 289 (2003) 2801-2809
6. O'Donnell D.R., and Carrington D. Peripheral blood lymphopenia and neutrophilia in children with severe respiratory syncytial virus disease. Pediatr Pulmonol 34 (2002) 128-130
7. Roe M.F.E., Bloxham D.M., White D.K., Ross-Russell R.I., Tasker R.T.C., and O'donnell D.R. Lymphocyte apoptosis in acute respiratory syncytial virus bronchiolitis. Clin Exp Immunol 137 (2004) 139-145
8. Leroy E.M., Baize S., Debre P., Lansoud-Soukate J., and Mavoungou E. Early immune responses accompanying human asymptomatic Ebola infections. Clin Exp Immunol 124 (2001) 453-460
9. Dandekar A.A., and Perlman S. Immunopathogenesis of coronavirus infections: implications for SARS. Nat Rev Immunol 5 (2005) 917-927
10. Gu J., Gong E., Zhang B., et al. Multiple organ infection and the pathogenesis of SARS. J Exp Med 202 (2005) 415-424
11. Panesar N.S. Lymphopenia in SARS. Lancet 361 (2003) 1985
12. Thompson B.T. Glucocorticoids and acute lung injury. Crit Care Med 31 (2003) S253-S257
13. Tasker R.C., Roe M.F.E., Bloxham D.M., White D.K., Ross-Russell R.I., and O'Donnell D.R. The neuroendocrine stress response and severity of acute respiratory syncytial virus bronchiolitis in infancy. Intensive Care Med 30 (2004) 2257-2262
14. Panesar N.S., Lam C.W.K., Chan M.H.M., Wong C.K., and Sung J.J.Y. Lymphopenia and neutrophilia in SARS are related to the prevailing serum cortisol. Eur J Clin Invest 34 (2004) 382-384
15. Panesar NS. Lymphopenia in SARS: apoptosis definitely is involved, but is it glucocorticoid or virus induced? BMJ; 2003. Available from: http://www.bmj.com/cgi/eletters/327/7415/620-b#37016.
16. Robertson A.M., Bird C.C., Waddell A.W., and Currie A.R. Morphological aspects of glucocorticoid-induced cell death in human lymphoblastoid cells. J Pathol 126 (1978) 181-187
17. Fauci A.S., Dale D.C., and Balow J.E. Glucocorticosteroid therapy: mechanisms of action and clinical considerations. Ann Int Med 84 (1976) 304-315
18. Norris D.A., Fine R., Weston W.L., and Spector S. Monocyte cellular function in asthmatic patients on alternate-day steroid therapy. J Allergy Clin Immunol 61 (1978) 255-260
19. Petrovsky N., McNair P., and Harrison L.C. Diurnal rhythms of pro-inflammatory cytokines: regulation by plasma cortisol and therapeutic implications. Cytokine 10 (1998) 307-312
20. Thomson S.P., McMahon L.J., and Nugent C.A. Endogenous cortisol: a regulator of the number of lymphocytes in peripheral blood. Clin Immunol Immunopathol 17 (1980) 506-514
21. Kronfol Z., Turner R., Nasrallah H., and Winokur G. Leukocyte regulation in depression and schizophrenia. Psychiat Res 13 (1984) 13-18
22. Fauci A.S. Mechanisms of corticosteroid action on lymphocyte subpopulations. I. Redistribution of circulating T and B lymphocytes to the bone marrow. Immunology 28 (1975) 669-680
23. Herold M., McPherson K., and Reichardt H. Glucocorticoids in T cell apoptosis and function. Cell Mol Life Sci 63 (2006) 60-72
24. Cameron R.G., Black P.N., Braan C., and Browett P.J. A comparison of the effects of oral prednisone and inhaled beclomethasone dipropionate on circulating leukocytes. Aust N Z J Med 26 (1996) 800-805
25. Wong C.K., Lam C.W.K., Wu A.K.L., et al. Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome. Clin Exp Immunol 136 (2004) 95-103
26. Jiang Y., Xu J., Zhou C., et al. Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome. Am J Respir Crit Care Med 171 (2005) 850-857
27. Law H.K.W., Cheung C.Y., Ng H.Y., et al. Chemokine up-regulation in SARS-coronavirus-infected, monocyte-derived human dendritic cells. Blood 106 (2005) 2366-2374
28. Tang N.L.S., Chan P.K.S., Wong C.K., et al. Early enhanced expression of interferon-inducible protein-10 (CXCL-10) and other chemokines predicts adverse outcome in severe acute respiratory syndrome. Clin Chem 51 (2005) 2333-2340
29. Zhang Y., Li J., Zhan Y., et al. Analysis of serum cytokines in patients with severe acute respiratory syndrome. Infect Immunol. 72 (2004) 4410-4415
30. Kelso A., and Munck A. Glucocorticoid inhibition of lymphokine secretion by alloreactive T lymphocyte clones. J Immunol 133 (1984) 784-791
31. Pawlik A., Baskiewicz-Masiuk M., Machalinski B., Kurzawski M., and Gawronska-Szklarz B. Involvement of C3435T and G2677T multidrug resistance gene polymorphisms in release of cytokines from peripheral blood mononuclear cells treated with methotrexate and dexamethasone. Eur J Pharmacol 528 (2005) 27-36
32. Oba Y. The use of corticosteroids in SARS. N Engl J Med 348 (2003) 2034-2035
33. Wang H., Ding Y., Li X., Yang L., Zhang W., and Kang W. Fatal aspergillosis in a patient with SARS who was treated with corticosteroids. N Engl J Med 349 (2003) 507-508
34. Kelso A. Cytokines and their receptors: an overview. Ther Drug Monit 22 (2000) 40-43
35. Kelso A. Th1 and Th2 subsets: paradigms lost?. Immunol Today 16 (1995) 374-379
36. Panesar N.S. Glucocorticoid treatment of patients with SARS: implications for mechanisms of immunopathology. Nat Rev Immunol 6 4 (2006) 334 10.1038/nri1835-c1)